CN1413662A - Decoction for positive reaction of hepatitis B transformation to negative - Google Patents

Decoction for positive reaction of hepatitis B transformation to negative Download PDF

Info

Publication number
CN1413662A
CN1413662A CN02131724A CN02131724A CN1413662A CN 1413662 A CN1413662 A CN 1413662A CN 02131724 A CN02131724 A CN 02131724A CN 02131724 A CN02131724 A CN 02131724A CN 1413662 A CN1413662 A CN 1413662A
Authority
CN
China
Prior art keywords
grams
radix
hepatitis
rhizoma
decoction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN02131724A
Other languages
Chinese (zh)
Other versions
CN1223361C (en
Inventor
林现举
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021317240A priority Critical patent/CN1223361C/en
Publication of CN1413662A publication Critical patent/CN1413662A/en
Application granted granted Critical
Publication of CN1223361C publication Critical patent/CN1223361C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine in the form of decoction for treating hepatitis B is prepared from 22 Chinese-medicinal materials including white peony root, Chuan-xiong rhizome, Chinese angelica root, red sage root, etc. Its advantages are high effective rate (98%), high cure rate (more than 85%), low cost, no recurrence and no toxic by-effect.

Description

Decoction for positive reaction of hepatitis B transformation to negative
The present invention relates to a kind of medicine for the treatment of hepatitis B virus.
At present the drug main of treatment hepatitis B will with the grand liver-protecting tablet of sharp liver to hepatitis B disease killing action a little less than, the DeGrain of turning out cloudy of HBAg, treatment time are long, and these medicine medicine high prices are expensive, side effect big, cure the symptoms, not the disease, can not eradicate, cure rate is low, easy recurrence.
The purpose of this invention is to provide a kind of medicine for the treatment of hepatitis B virus, curative effect height of the present invention, do not have return jumpings, have no side effect, cost is low, do not recur after healing, this medicine effective percentage can reach 98%, cure rate can reach more than 85%.
The present invention adopts following principle to realize: the present invention adopts prescription handed down from one's ancestors to go through the actual experiment in more than 100 year; mainly enter and suppress virus behind the human body and in human body, duplicate and excise hepatitis B virus gene and connect and inside and outside liver, kill virus, get rid of externally, have the principle effect of protection cell to realize by medicament of the present invention.
Owing to adopt such scheme, can make the present invention treat hepatitis B virus, cost is low, cure rate is high, do not have and return jumpings, do not recur after having no side effect, healing, and effective percentage can reach 98%, and cure rate can reach more than 85%.
Below be the present invention's prescription and processing technology in detail: detailed prescription of the present invention: Radix Codonopsis 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Bupleuri 10 grams, the Radix Paeoniae Alba 9 grams, Rhizoma Chuanxiong 10 grams, Radix Angelicae Sinensis 9 grams, Radix Salviae Miltiorrhizae 10 grams, Radix Et Rhizoma Rhei 10 grams, Fructus Gardeniae 10 grams, Flos Lonicerae 15 grams, Herba Taraxaci 15 grams, Cymbidium ensifolium (L.) Sw. root 12 grams, Herba Artemisiae Scopariae 12 grams, Pericarpium Citri Reticulatae Viride 8 grams, the Radix Aucklandiae 8 grams, Herba Patriniae 10 grams, Fructus Ligustri Lucidi 12 grams, Fructus Lycii 10 grams, Colla Plastri Testudinis 10 grams, Talcum 12 grams, fresh Rhizoma Imperatae 30 grams, Radix Glycyrrhizae 3 grams.
Processing technology of the present invention: the selected decontamination of above medicine is got it filled by formula ratio, and slow fire was fried in shallow oil 10 minutes again after boiling with clear water 1000 gram immersions 30-60 minute, with very hot oven heat, filtered surplus medicine 300 grams.Instructions of taking: decoction being taken warmly, once a day, each one pair (one pair is whole medicaments of above prescription), one after each meal.

Claims (1)

1. medicine for the treatment of hepatitis B virus, it is made up of Radix Codonopsis 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Bupleuri 10 grams, the Radix Paeoniae Alba 9 grams, Rhizoma Chuanxiong 10 grams, Radix Angelicae Sinensis 9 grams, Radix Salviae Miltiorrhizae 10 grams, Radix Et Rhizoma Rhei 10 grams, Fructus Gardeniae 10 grams, Flos Lonicerae 15 grams, Herba Taraxaci 15 grams, Cymbidium ensifolium (L.) Sw. root 12 grams, Herba Artemisiae Scopariae 12 grams, Pericarpium Citri Reticulatae Viride 8 grams, the Radix Aucklandiae 8 grams, Herba Patriniae 10 grams, Fructus Ligustri Lucidi 12 grams, Fructus Lycii 10 grams, Colla Plastri Testudinis 10 grams, Talcum 12 grams, fresh Rhizoma Imperatae 30 grams, Radix Glycyrrhizae 3 grams.
CNB021317240A 2002-09-09 2002-09-09 Decoction for positive reaction of hepatitis B transformation to negative Expired - Fee Related CN1223361C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021317240A CN1223361C (en) 2002-09-09 2002-09-09 Decoction for positive reaction of hepatitis B transformation to negative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021317240A CN1223361C (en) 2002-09-09 2002-09-09 Decoction for positive reaction of hepatitis B transformation to negative

Publications (2)

Publication Number Publication Date
CN1413662A true CN1413662A (en) 2003-04-30
CN1223361C CN1223361C (en) 2005-10-19

Family

ID=4746707

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021317240A Expired - Fee Related CN1223361C (en) 2002-09-09 2002-09-09 Decoction for positive reaction of hepatitis B transformation to negative

Country Status (1)

Country Link
CN (1) CN1223361C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314410C (en) * 2005-06-26 2007-05-09 史淑珍 Chinse medicinal formulation for health-care and heptitis treatment
CN105148102A (en) * 2015-10-27 2015-12-16 郑耀玲 Traditional Chinese medicine preparation for treating hepatitis B and preparing method thereof
CN107029133A (en) * 2017-04-20 2017-08-11 蔡信和 A kind of natural biology degradation element for killing hepatitis B and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314410C (en) * 2005-06-26 2007-05-09 史淑珍 Chinse medicinal formulation for health-care and heptitis treatment
CN105148102A (en) * 2015-10-27 2015-12-16 郑耀玲 Traditional Chinese medicine preparation for treating hepatitis B and preparing method thereof
CN107029133A (en) * 2017-04-20 2017-08-11 蔡信和 A kind of natural biology degradation element for killing hepatitis B and preparation method thereof

Also Published As

Publication number Publication date
CN1223361C (en) 2005-10-19

Similar Documents

Publication Publication Date Title
CN100496586C (en) Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion
CN101411392B (en) Chinese herbal medicine additive agent for preventing and treating pig viral enteritis
CN103127406B (en) Composite kidney-benefiting medicine
CN1112201C (en) Chinese medicine for curing hepatitis B and cirrhosis ascites
CN1315457C (en) Bath lotion for chilblain nursing and preparation method thereof
CN105998980A (en) Anti-virus traditional Chinese medicinal composition and preparation method thereof
CN1178675C (en) Toxin-discharging liver-fortifying medicine
CN1186687A (en) Cancer preventing curing medicine series and its preparation
CN101167932A (en) Traditional Chinese medicine for treating chronic hepatitis B
CN103142920A (en) Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof
CN1218706C (en) Hepatitis B treaitng pill
CN102406765B (en) Traditional Chinese medicine composition for treating acne
CN104758529A (en) Traditional Chinese medicine composition for treating common cold due to wind-cold
CN101700364B (en) Thrombolytic and lipid-lowering pill
CN1223361C (en) Decoction for positive reaction of hepatitis B transformation to negative
CN104644857A (en) Traditional Chinese medicine formula for treating acnes
CN101152540A (en) Traditional Chinese medicine for treating chronic hepatitis
CN1385191A (en) Medicine for treating liver disease
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN1245205C (en) Chinese medicine for treating alimentary system malignant tumour
CN1263479C (en) Chinese traditional medicine for treating cardiopathy
CN101670047A (en) Hepatitis B treating soup
CN103316283A (en) Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof
CN102397403A (en) Medicine for treating kidney dysfunction
CN1092970C (en) Compound Chinese medicine for treating hepatocholepathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee